Dabigo 75 mg
| SKU | 2637 |
|---|---|
| Generic For | Pradaxa |
| Manufacturer | MSN Laboratories Ltd |
| Active Ingredient | Dabigatran Etexilate |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Capsule/s | US$ 0.62 | US$ 18.60 | |||
|
|||||
| 60 Capsule/s | US$ 0.56 | US$ 33.4810%US$ 37.20 | |||
|
|||||
| 90 Capsule/s | US$ 0.53 | US$ 47.4315%US$ 55.80 | |||
|
|||||
Dabigo 75mg contains the active component of Dabigatran, a blood-thinning medicine that lowers the risk of blood clots forming in the body. It is a prescription medicine for:
- Lowering the chance of stroke and blood clots in adults with the medical condition of atrial fibrillation (irregular heart rhythm). In the case of atrial fibrillation, part of the heart does not beat properly. The condition may lead to the formation of blood clots and increases the risk of developing a stroke.
- Treating blood clots in the veins of lungs and legs after a patient receives a medicine to treat blood clots for up to 5 to 10 days.
- Reducing the chance of blood clots from developing again in the veins of your lungs and legs after patients have received blood clot treatment.
- Preventing blood clots in lungs and veins after an individual has just undergone hip replacement surgery.
Dabigo can also be prescribed to treat blood clots in pediatrics 8 years to under 18 years of age who have medicine via intravenous/Intramuscular route to treat their blood clots for at least five days. It lowers the risk of blood clots developing again in children aged 8 to under 18 years who have received blood clot treatment.
Precaution with Dabigatran
The use of Dabigo 75 mg is contraindicated in the following conditions:
- Known hypersensitivity to Dabigatran or any other ingredients in the formulation.
- Severe kidney disease
- Active bleeding, including gastrointestinal bleeding.
- Lesions at risk of clinically significant bleeding, e.g., extensive cerebral infarction within the last six months, active peptic ulcer disease with recent bleeding, active peptic ulcer with recent bleeding.
- Combination with oral ketoconazole
- Prosthetic heart valve requiring anticoagulation
- Nursing women
The effects of Dabigo on pregnancy and the unborn child are not known. The medicine should not be used during pregnancy unless recommended by a doctor, as it is not safe to do so. Women of reproductive potential should avoid becoming pregnant while taking the medicine. Furthermore, it is best to avoid breastfeeding while taking a Dabigatran formulation. Dabigatran has no known effects on the ability to drive or use machines. It is still unknown if the blood-thinning medicine is safe and effective in kids with atrial fibrillation not caused by heart valve conditions or in children who have had hip replacement surgery.
Side effects of Dabigatran
Allergic reactions: Some adults receiving Dabigo capsules have been reported to develop symptoms of an allergic reaction. Consult your healthcare professional immediately in the event of an allergic reaction. Common symptoms include rash, itching, and hives. Seek immediate medical advice if serious allergic symptoms with the use of a Dabigatran capsule occur, and these may include:
- Swelling of your face or tongue
- Feeling dizzy or faint
- Chest pain or chest tightness
- Trouble breathing or wheezing
Common side effects of the medicine in adults and children include upset stomach, indigestion, burning, and stomach pain or discomfort. Children usually may experience nausea, vomiting, and diarrhea.
How to use Dabigatran?
Dabigo is for oral use. It is available in capsule form and can be taken before or after meals. The tablet should be swallowed whole with an adequate amount of water to facilitate delivery to the stomach. Patients are instructed not to open the capsule, as this increases the likelihood of bleeding. The doctor recommends Pradaxa-coated granules as the best option for children under eight years who are prescribed Dabigatran.
Dabigo 75 mg should not be discontinued without consulting a doctor. Sudden discontinuation may increase your risk of developing a stroke or forming blood clots. Patients should be instructed to talk to their contact healthcare provider if they develop stomach-related symptoms such as dyspepsia. Let your doctor decide how long a medication needs to be taken.
In adults, Dabigo capsules are usually recommended two times a day. The medicines may need to be taken once daily for treatment after hip surgery. It is recommended that the capsule be swallowed with a glass of water. If the child cannot swallow the capsule, avoid emptying the pellets from the capsules and seek immediate doctor’s advice.
In children: It is recommended that they take Dabigo capsules two times a day. It is usually advised to take one dose in the evening, approximately twelve hours before bedtime.
The medication can be consumed before or after consuming food. Stomach problems can be relieved if taken with food.
Treatment with Dabigo 75 mg in patients with severe kidney disease is contraindicated. Those with moderate renal insufficiency can be given a lower dose, as dose reduction is recommended in such patients. Doctors may recommend dose reduction for older patients aged 75 years and above.
Login
Sign Up
Login
Sign Up